Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg

NCT06965998 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study of Rivaroxaban for CeREbral Venous Thrombosis

NCT03178864 ·Status: COMPLETED ·Phase: PHASE2

Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients

NCT03100071 ·Status: UNKNOWN

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

NCT02746185 ·Status: COMPLETED ·Phase: PHASE3

Rivaroxaban Anticoagulation for Superficial Vein Thrombosis

NCT02123524 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients

NCT06149533 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Prophylactic Anticoagulation for Catheter-related Thrombosis

NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

NCT03282643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

NCT00199602 ·Status: COMPLETED ·Phase: PHASE3

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 ·Status: COMPLETED ·Phase: PHASE2

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

NCT05033314 ·Status: TERMINATED ·Phase: PHASE3

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

NCT04979780 ·Status: COMPLETED

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

NCT05112666 ·Status: COMPLETED

Recanalization Rate of Acute DVT

NCT06145269 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

NCT05150938 ·Status: COMPLETED

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

NCT01989845 ·Status: COMPLETED ·Phase: PHASE4

XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis

NCT02506985 ·Status: TERMINATED ·Phase: PHASE4

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

NCT01602445 ·Status: COMPLETED

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

NCT01130025 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

NCT02627053 ·Status: UNKNOWN ·Phase: PHASE3

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

NCT00024297 ·Status: COMPLETED ·Phase: NA

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

NCT03214172 ·Status: COMPLETED

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention

NCT06103266 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

NCT00375076 ·Status: COMPLETED ·Phase: PHASE3

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

NCT06887270 ·Status: NOT_YET_RECRUITING ·Phase: NA